Bunzl share price rises as insider share buy is disclosed; U.S. jobs report ahead
9 January 2026
1 min read

Bunzl share price rises as insider share buy is disclosed; U.S. jobs report ahead

London, Jan 9, 2026, 11:40 GMT — Regular session

Bunzl (BNZL.L) shares rose 1.1% to 2,068 pence in late morning trade on Friday, edging ahead of the FTSE 100, up 0.46%. The stock traded between 2,042 and 2,074 pence on the day and remains well below its 52-week high of 3,488. 1

The move lands as investors keep a close watch on distributors’ margins and pricing power into 2026, with Bunzl set to spell out a fuller outlook at its annual results. Small disclosures can matter when the market is trying to judge whether a steady business is getting steadier, or just holding the line.

In a Dec. 17 pre-close statement, Bunzl said it expected 2025 adjusted operating profit in line with expectations, with operating margin around 7.6% — operating margin is profit as a share of sales. It forecast moderate 2026 revenue growth at constant exchange rates, which strips out currency swings, but said operating margin should be slightly down year-on-year. Chief Executive Frank van Zanten said the acquisition pipeline “remain[s] active” and the group looked to “an improved year for acquisitions in 2026.” 2

A regulatory filing on Wednesday showed James McCool, Bunzl’s chief executive for North America, acquired 547 shares at 20.4244 pounds each after the company’s 2025 interim dividend was reinvested. The filing described it as a non-discretionary transaction, meaning the shares were bought automatically under a dividend reinvestment arrangement. 3

More broadly, investors were also bracing for the U.S. employment report due later on Friday, a release that can move bond yields and, by extension, equity valuations. Economists polled by Reuters expect 60,000 jobs were added in December and the unemployment rate rose to 4.5%; “businesses are very cautious about taking on new workers,” Sal Guatieri at BMO Capital Markets said. 4

For Bunzl, the next company catalyst is its results for the year ended Dec. 31, 2025, scheduled for March 2, according to its financial calendar. Investors will be watching for how the group frames 2026 margin pressures, the pace of acquisitions and any updates on capital returns. 5

On the chart, traders point to the 2,000p area as a psychological floor after the stock’s 52-week low at 1,995p, while Friday’s high around 2,074p marks a near-term hurdle.

But the bounce can fade quickly. A softer pricing backdrop or higher wage and transport costs could squeeze margins again, and a jump in yields after the U.S. jobs numbers would test appetite for defensive UK names.

The next test is the U.S. payrolls release later on Friday, then Bunzl’s March 2 results, when investors will look for firmer signals on 2026 margins and dealmaking.

Stock Market Today

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

Disney stock ends week higher after Friday bounce — what to watch for DIS next week

7 February 2026
Disney shares closed up 3.6% at $108.70 Friday, recovering from earlier losses as U.S. stocks rallied and the Dow topped 50,000. Investors are watching Super Bowl streaming economics and Disney’s CEO transition, with Josh D’Amaro set to take over at the March 18 meeting. Disney reported quarterly revenue of $25.98 billion and adjusted EPS of $1.63, while segment operating income fell 9% to $4.6 billion.
Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

Novo Nordisk stock: Class B shares face Monday test after FDA squeeze forces Hims to pull $49 Wegovy copycat

7 February 2026
Novo Nordisk Class B shares closed up 5.3% at 295.50 Danish crowns in Copenhagen after Hims & Hers said it would stop offering a compounded pill version of Wegovy following U.S. regulatory warnings. The move came after Novo called the Hims product “illegal mass compounding” and threatened legal action. Shares had fallen nearly 8% Thursday after Hims launched the pill. Trading resumes Monday.
Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

Linde stock price falls as LIN heads into weekend; JPMorgan downgrade and guidance in focus

7 February 2026
Linde plc shares fell 2.5% to $448.24 Friday after reporting Q4 sales up 6% to $8.76 billion and adjusted EPS of $4.20. The company guided 2026 adjusted EPS to $17.40–$17.90, below analyst consensus. JPMorgan downgraded the stock, while Morgan Stanley and UBS raised price targets. Linde repurchased $1.4 billion in shares in Q4 and returned $7.4 billion to shareholders in 2025.
Vodafone stock watchers have 3 things to track today: India relief, buybacks, and Feb. 5
Previous Story

Vodafone stock watchers have 3 things to track today: India relief, buybacks, and Feb. 5

Antofagasta stock jumps after Goldman upgrade as copper prices keep miners in focus
Next Story

Antofagasta stock jumps after Goldman upgrade as copper prices keep miners in focus

Go toTop